O-2172
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Identifiers | |
---|---|
|
|
PubChem (CID) | 11778793 |
ChemSpider | 9953475 N |
Chemical and physical data | |
Formula | C14H16Cl2O2 |
Molar mass | 287.181 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
NY (what is this?) (verify) |
O-2172 is a drug developed by Organix Inc, which acts as a stimulant and potent dopamine reuptake inhibitor. It is an analogue of methylphenidate where the phenyl ring has had a 3,4-dichloro substitution added, and the piperidine ring has been replaced by cyclopentane. It is around 1/3 the potency of methylphenidate, demonstrating that even with the important binding group of the nitrogen lone pair removed entirely, selective DAT binding and reuptake inhibition is still possible.[1][2]
See also[edit]
References[edit]
- ^ Meltzer PC, Wang P, Blundell P, Madras BK. Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. Journal of Medicinal Chemistry. 2003 Apr 10;46(8):1538-45. PMID 12672255
- ^ Runyon SP, Carroll FI. Dopamine transporter ligands: recent developments and therapeutic potential. Current Topics in Medicinal Chemistry. 2006;6(17):1825-43. PMID 17017960
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=O-2172&oldid=737623884"
Hidden categories:
- Pages using PMID magic links
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles